肾素动力学预测低血压危重患者院内死亡优于乳酸动力学
这项前瞻性观察性队列研究纳入53例在2020年1月期间持续使用血管升压药超过6小时、维持平均动脉压≥65 mmHg的成人患者,在入组时及24、48、72小时测血浆肾素浓度,并按常规标准测全血乳酸。结果显示ln-肾素浓度斜率与院内死亡独立相关(校正OR 10.35,95%CI 1.40-76.34,P=0.022),而ln-乳酸斜率不相关(校正OR 4.78,95%CI 0.03-772.64,P=0.55);广义估计方程显示ln-肾素(校正OR 1.18,95%CI 1.02-1.37,P=0.025)和ln-乳酸(校正OR 2.38,95%CI 1.05-5.37,P=0.037)均与死亡相关。初始肾素可预测院内死亡(AUC 0.682,95%CI 0.503-0.836,P=0.05),初始乳酸不能(AUC 0.615,95%CI 0.413-0.803,P=0.27);峰值肾素(AUC 0.728,95%CI 0.547-0.888,P=0.01)与峰值乳酸(AUC 0.746,95%CI 0.584-0.876,P=0.01)均为中等区分度,两者区分能力无显著差异。作者认为血浆肾素动力学可能优于乳酸动力学用于预测此类患者的死亡。
要点
- 在持续用血管升压药>6小时、MAP≥65 mmHg的低血压危重患者中,ln-肾素浓度斜率与院内死亡独立相关(校正OR 10.35,95%CI 1.40-76.34,P=0.022)。
- ln-乳酸浓度斜率与院内死亡无独立相关(校正OR 4.78,95%CI 0.03-772.64,P=0.55)。
- ln-肾素斜率每增加1个单位,死亡比值增加约10倍;作者据此认为肾素动力学可能优于乳酸动力学。
- 初始肾素可预测院内死亡(AUC 0.682,95%CI 0.503-0.836,P=0.05),初始乳酸不能(AUC 0.615,95%CI 0.413-0.803,P=0.27);峰值肾素与峰值乳酸均为中等区分度且两者无显著差异。
- 各时间点肾素>40 pg/mL者在非存活者中比例更高,而乳酸>2 mmol/L未见此显著关联。
适用人群与场景
- 2020年1月期间在三级学术ICU中持续使用血管升压药超过6小时以维持平均动脉压≥65 mmHg的成人低血压危重患者。
诊断标准与关键阈值
- 肾素正常上限阈值为40 pg/mL,原文报告各时间点肾素高于此阈值者在非存活者中比例更高。
- 乳酸正常上限阈值为2 mmol/L,原文报告各时间点乳酸高于此阈值与院内死亡的关联不显著。
处置流程与药物剂量
- 入组时及24、48、72小时测血浆肾素浓度。
- 全血乳酸按常规标准诊疗进行测量。
研究设计与关键结果
- 研究类型为前瞻性观察性队列研究,单中心三级学术ICU,共53例患者,获得197份肾素样本和148份乳酸样本。
- ln-肾素浓度斜率与院内死亡独立相关(校正OR 10.35,95%CI 1.40-76.34,P=0.022),ln-乳酸浓度斜率不相关(校正OR 4.78,95%CI 0.03-772.64,P=0.55)。
- 广义估计方程模型显示ln-肾素(校正OR 1.18,95%CI 1.02-1.37,P=0.025)和ln-乳酸(校正OR 2.38,95%CI 1.05-5.37,P=0.037)均与院内死亡相关。
- 初始肾素预测院内死亡AUC 0.682(95%CI 0.503-0.836,P=0.05),初始乳酸AUC 0.615(95%CI 0.413-0.803,P=0.27)。
- 峰值肾素AUC 0.728(95%CI 0.547-0.888,P=0.01),峰值乳酸AUC 0.746(95%CI 0.584-0.876,P=0.01),两者区分能力无显著差异。
- 各研究时间点肾素值超过正常阈值40 pg/mL者在非存活者中比例高于存活者,但乳酸未见此显著关联。
- 作者结论:肾素浓度在72小时内呈阳性变化率(而非乳酸浓度)与院内死亡相关;ln-肾素斜率每增加1个单位死亡比值增加10倍;肾素>40 pg/mL(而非乳酸>2 mmol/L)与院内死亡相关。
证据类型、等级与局限
- 证据类型:前瞻性观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为血浆肾素动力学可能优于乳酸动力学用于预测低血压危重患者的死亡。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Whole blood lactate concentration is widely used in shock states to assess perfusion. We aimed to determine if the change in plasma renin concentration over time would be superior to the change in lactate concentration for predicting in-hospital mortality in hypotensive patients on vasopressors.
DESIGN: Prospective, observational cohort study.
SETTING: Tertiary academic ICU.
PATIENTS: Adult patients on vasopressors for greater than 6 hours to maintain a mean arterial pressure greater than or equal to 65 mm Hg during January 2020.
INTERVENTIONS: Plasma renin concentrations were measured at enrollment and at 24, 48, and 72 hours. Whole blood lactate measurements were performed according to normal standard of care. Logistic regression was performed to evaluate whether the change in renin or lactate concentration could predict in-hospital mortality. Generalized estimating equations were used to analyze the association between renin and lactate concentration and in-hospital mortality. The area under the receiver operating characteristics curve was performed to measure the discriminative ability of initial and peak renin and lactate concentration to predict mortality. The association between renin and lactate concentration above the upper limit of normal at each timepoint with in-hospital mortality was also examined.
MEASUREMENTS AND MAIN RESULTS: The study included 197 renin and 148 lactate samples obtained from 53 patients. The slope of the natural log (ln) of renin concentration was independently associated with mortality (adjusted odds ratio, 10.35; 95% CI, 1.40-76.34; p = 0.022), but the slope of ln-lactate concentration was not (adjusted odds ratio, 4.78; 95% CI, 0.03-772.64; p = 0.55). The generalized estimating equation models found that both ln-renin (adjusted odds ratio, 1.18; 95% CI, 1.02-1.37; p = 0.025) and ln-lactate (adjusted odds ratio, 2.38; 95% CI, 1.05-5.37; p = 0.037) were associated with mortality. Area under the receiver operating characteristics curve analysis demonstrated that initial renin could predict in-hospital mortality with fair discrimination (area under the receiver operating characteristics curve, 0.682; 95% CI, 0.503-0.836; p = 0.05), but initial lactate could not (area under the receiver operating characteristics curve, 0.615; 95% CI, 0.413-0.803; p = 0.27). Peak renin (area under the receiver operating characteristics curve, 0.728; 95% CI, 0.547-0.888; p = 0.01) and peak lactate (area under the receiver operating characteristics curve, 0.746; 95% CI, 0.584-0.876; p = 0.01) demonstrated moderate discrimination. There was no significant difference in discriminative ability between initial or peak renin and lactate concentration. At each study time point, a higher proportion of renin values exceeded the threshold of normal (40 pg/mL) in nonsurvivors than in survivors, but this association was not significant for lactate.
CONCLUSIONS: Although there was no significant difference in the performance of renin and lactate when examining the absolute values of each laboratory, a positive rate of change in renin concentration, but not lactate concentration, over 72 hours was associated with in-hospital mortality. For each one-unit increase in the slope of ln-renin, the odds of mortality increased 10-fold. Renin levels greater than 40 pg/mL, but not lactate levels greater than 2 mmol/L, were associated with in-hospital mortality. These findings suggest that plasma renin kinetics may be superior to lactate kinetics in predicting mortality of hypotensive, critically ill patients.
参考来源
- Jeyaraju M, McCurdy MT, Levine AR, et al. Renin Kinetics Are Superior to Lactate Kinetics for Predicting In-Hospital Mortality in Hypotensive Critically Ill Patients. Crit Care Med. 2022. PMID: 34166293. doi:10.1097/CCM.0000000000005143
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。